VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Amgen Inc. vs Martin Marietta Materials, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Martin Marietta Materials, Inc.
MLM · NYSE
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Martin Marietta Materials, Inc.'s moat claims, evidence, and risks.
View MLM analysisComparison highlights
- Moat score gap: Martin Marietta Materials, Inc. leads (78 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Martin Marietta Materials, Inc. has 3 segments (52.4% in East Group).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Martin Marietta Materials, Inc. has 4 across 2.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Martin Marietta Materials, Inc.
East Group
Construction aggregates and asphalt products (crushed stone, sand & gravel; asphalt) in local/regional markets
United States (East/Southeast and adjacent regions)
Infrastructure agencies, construction contractors, and downstream materials producers (asphalt/ready-mix)
Quarry/mining operator and building materials producer/distributor
52.4%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
Martin Marietta Materials, Inc. strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Martin Marietta Materials, Inc. segments
Full profile >East Group
Oligopoly
West Group
Oligopoly
Specialties (formerly Magnesia Specialties)
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.